Imaging Immune Activation in COVID-19
a study on COVID-19
Covid19 SARS-CoV Infection PET-CT Imaging [18F]F-AraG COVID-19 Severe Acute Respiratory Syndrome [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
Lead Scientist at UCSF
- Timothy Henrich, MD
My laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic and stem cell transplantation approaches to HIV-1 cure. We are also involved in the design and implementation of novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.
- accepting new patients
- Start Date
- Completion Date
- CellSight Technologies, Inc.
- Phase 1 COVID-19 Research Study
- Study Type
- Expecting 20 study participants
- Last Updated